open access

Vol 6, No 5 (2005): Practical Diabetology
Original articles (submitted)
Published online: 2005-10-03
Get Citation

Perinatal outcome in women with gestational diabetes mellitus treated with Gensulin or regular human insulin during pregnancy

Ewa Wender-Ożegowska
Diabetologia Praktyczna 2005;6(5):223-229.

open access

Vol 6, No 5 (2005): Practical Diabetology
Original articles (submitted)
Published online: 2005-10-03

Abstract

INTRODUCTION. Gestational diabetes mellitus (GDM) is defined as a carbohydrate intolerance with variable severity with onset or first recognition during pregnancy. It develops during pregnancy as a consequence of physiological insulin resistence, that is caused by increased production of several diabetogenic hormones and is followed by maternal hyperglycemia that reflects a continuum of risk for adverse outcomes including neonatal morbidities such as macrosomia, birth trauma and neonatal hypoglycemia. Untreated GDM is associated with increased adverse outcome in pregnancy and the treatment results in perinatal outcome comparable to the general population. Aim of the study was to evaluate metabolic control and obstetrical results in the group of pregnant women with GDM treated with Polish human insulin (Gensulin).
MATERIAL AND METHODS. The study group consisted of 60 GDM pregnant women who required insulin treatment. Thirty of them were treated with Gensulin, and remaining 30 were treated with other human insulins. Insulin was introduced when despite the restricted diet, fasting glucose levels exceeded 5.3 mmol/l and 2-h postprandial levels exceeded 6.7 mmol/l. In both groups maternal age and prepregnancy body weight were analyzed. Weight gain during pregnancy, glucose metabolism and insulin requirement at the beginning of treatment and before delivery were also studied. At the last step of the study neonatal weight and condition were analyzed.
RESULTS. No difference in maternal age as well as in pre pregnancy weight was noticed between analyzed groups. In both groups sufficient metabolic control was achieved, by using similar insulin doses. Mean neonatal weight didn’t differ between both analyzed groups, however percentage of newborns with LGA was significantly lower in the group treated with lower Gensulin.
CONCLUSION. Treatment with Gensulin as well as with other human insulins enables proper management during pregnancy complicated with GDM and gives the chance for successful fetal outcome.

Abstract

INTRODUCTION. Gestational diabetes mellitus (GDM) is defined as a carbohydrate intolerance with variable severity with onset or first recognition during pregnancy. It develops during pregnancy as a consequence of physiological insulin resistence, that is caused by increased production of several diabetogenic hormones and is followed by maternal hyperglycemia that reflects a continuum of risk for adverse outcomes including neonatal morbidities such as macrosomia, birth trauma and neonatal hypoglycemia. Untreated GDM is associated with increased adverse outcome in pregnancy and the treatment results in perinatal outcome comparable to the general population. Aim of the study was to evaluate metabolic control and obstetrical results in the group of pregnant women with GDM treated with Polish human insulin (Gensulin).
MATERIAL AND METHODS. The study group consisted of 60 GDM pregnant women who required insulin treatment. Thirty of them were treated with Gensulin, and remaining 30 were treated with other human insulins. Insulin was introduced when despite the restricted diet, fasting glucose levels exceeded 5.3 mmol/l and 2-h postprandial levels exceeded 6.7 mmol/l. In both groups maternal age and prepregnancy body weight were analyzed. Weight gain during pregnancy, glucose metabolism and insulin requirement at the beginning of treatment and before delivery were also studied. At the last step of the study neonatal weight and condition were analyzed.
RESULTS. No difference in maternal age as well as in pre pregnancy weight was noticed between analyzed groups. In both groups sufficient metabolic control was achieved, by using similar insulin doses. Mean neonatal weight didn’t differ between both analyzed groups, however percentage of newborns with LGA was significantly lower in the group treated with lower Gensulin.
CONCLUSION. Treatment with Gensulin as well as with other human insulins enables proper management during pregnancy complicated with GDM and gives the chance for successful fetal outcome.
Get Citation

Keywords

gestational diabetes; insulin therapy; metabolic control

About this article
Title

Perinatal outcome in women with gestational diabetes mellitus treated with Gensulin or regular human insulin during pregnancy

Journal

Clinical Diabetology

Issue

Vol 6, No 5 (2005): Practical Diabetology

Pages

223-229

Published online

2005-10-03

Bibliographic record

Diabetologia Praktyczna 2005;6(5):223-229.

Keywords

gestational diabetes
insulin therapy
metabolic control

Authors

Ewa Wender-Ożegowska

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Diabetologia Kliniczna dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl